• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Ablation, radiotherapy boost lung cancer patients' survival

Article

Patients with inoperable lung cancer treated with a combination of thermal ablation and radiotherapy were able to add two years to their survival times, according to Brown University Medical School researchers.

Dr. Damian Dupuy, an interventional radiologist at Brown, and colleagues enrolled 41 patients with inoperable stage I/II non-small cell lung cancer tumors who underwent thermal ablation and radiotherapy between 1998 and 2005. The investigators performed 37 radiofrequency and four microwave ablation procedures, followed within 90 days by either external-beam radiotherapy or brachytherapy in 27 and 14 patients, respectively (J Vasc Interv Radiol 2006;17[7]:1117-1124).

None of the patients were expected to live longer than one year, according to the panel of specialists who selected them for the study. The combination therapy, however, prolonged the patients' lives about two years beyond that point.

Recent Videos
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1
Addressing Cybersecurity Issues in Radiology
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.